ANXA5 and systemic sclerosis: The clinical study by Habeeb et al. indicated that patients with systemic sclerosis (SSc) have anti-ANXA5 antibodies in their serum and that higher antibody titers are associated with more severe vascular damage (Habeeb et al., 2010; Sugiura and Muro, 1999).